Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Disease Progression × Genitourinary × Clear all

Phase

Phase NA 9 Phase 2 4 Phase 4 2 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 6 Plasma cell 3 CNS 3 Other solid neoplasm 2 Gastrointestinal 2 Sarcoma 1 Other hematologic neoplasm 1 Lymphoid 1 Gynecologic 1 Genitourinary 1 Dermatologic 1 Breast 1

Conditions

Prostatic Neoplasms 587 Carcinoma, Renal Cell 346 Carcinoma, Non-Small-Cell Lung 212 Urinary Bladder Neoplasms 208 Breast Neoplasms 194 Ovarian Neoplasms 168 Melanoma 168 Neoplasms 160 Kidney Neoplasms 140 Colorectal Neoplasms 140 Neoplasm Metastasis 112 Pancreatic Neoplasms 110 Carcinoma, Transitional Cell 108 Lung Neoplasms 105 Stomach Neoplasms 94 Sarcoma 92 Squamous Cell Carcinoma of Head and Neck 91 Head and Neck Neoplasms 80 Uterine Cervical Neoplasms 76 Carcinoma, Hepatocellular 69 Triple Negative Breast Neoplasms 67 Esophageal Neoplasms 64 Endometrial Neoplasms 64 Colonic Neoplasms 55 Wilms Tumor 53 Small Cell Lung Carcinoma 49 Neuroblastoma 45 Carcinoma, Ovarian Epithelial 44 Testicular Neoplasms 42 Liver Neoplasms 40

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01692262 2014-06-19

PYRUS

AstraZeneca

Phase 1 Completed

Prostatic Neoplasms, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡